MedPath

FLULAVAL TETRA

FLULAVAL TETRA

Approved
DIN Number

02420783

Drug Class

Human

Market Date

Oct 14, 2015

Company
HC

ID Biomedical Corporation of Quebec

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02420783
AIG Number0455410001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

HAEMAGGLUTININ-STRAIN A (H1N1)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H1N1)
HAEMAGGLUTININ-STRAIN A (H3N2)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H3N2)
HAEMAGGLUTININ-STRAIN B (VICTORIA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (VICTORIA)
HAEMAGGLUTININ-STRAIN B (YAMAGATA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (YAMAGATA)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.